Cargando…

Exercise stress echocardiography: Where are we now?

Exercise stress echocardiography (ESE) is a widely used diagnostic test in cardiology departments. ESE is mainly used to study patients with coronary artery disease; however, it has increasingly been used in other clinical scenarios including valve pathology, congenital heart disease, hypertrophic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cotrim, Carlos Alberto, Café, Hugo, João, Isabel, Cotrim, Nuno, Guardado, Jorge, Cordeiro, Pedro, Cotrim, Hortense, Baquero, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900523/ https://www.ncbi.nlm.nih.gov/pubmed/35316975 http://dx.doi.org/10.4330/wjc.v14.i2.64

Ejemplares similares

Intraventricular gradients—When we have to “exercise” our minds: A case report
por: Cotrim, Nuno, et al.
Publicado: (2023)

Exercise-Induced Intraventricular Gradients As a Potential Cause of Sudden Cardiac Death
por: Cotrim, Carlos A, et al.
Publicado: (2023)

The Importance of Left Ventricular Outflow Tract and Mid-Ventricular Gradients in Stress Echocardiography: A Narrative Review
por: Cotrim, Carlos, et al.
Publicado: (2023)

What Is Really a Nonobstructive Hypertrophic Cardiomyopathy? The Importance of Orthostatic Factor in Exercise Echocardiography
por: Cotrim, Carlos, et al.
Publicado: (2011)

Children’s Understanding of Informed Assents in Research Studies
por: Cotrim, Hortense, et al.
Publicado: (2021)

The usefulness of contrast during exercise echocardiography for the assessment of systolic pulmonary pressure
por: Lopes, Luis R, et al.
Publicado: (2008)

Efficacy of beta-blocker therapy in symptomatic athletes with exercise-induced intra-ventricular gradients
por: Cotrim, Carlos, et al.
Publicado: (2010)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
por: Loureiro, Maria José, et al.
Publicado: (2007)

Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise
por: Cotrim, Carlos, et al.
Publicado: (2013)

Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy
por: Miranda, Rita, et al.
Publicado: (2008)

Need for a standardized protocol for stress echocardiography in provoking subaortic and valvular gradient in various cardiac conditions
por: Petkow Dimitrow, Pawel, et al.
Publicado: (2014)

Brazilian infectious diseases specialists: who and where are they?
por: Cassenote, Alex Jones Flores, et al.
Publicado: (2016)

Exercise-induced intra-ventricular gradients as a frequent potential cause of myocardial ischemia in cardiac syndrome X patients
por: Cotrim, Carlos, et al.
Publicado: (2008)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Exercise-induced pulmonary hemorrhage: where are we now?
por: Poole, David C, et al.
Publicado: (2016)

Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report
por: Cotrim, Carlos, et al.
Publicado: (2007)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

From Nonalcoholic Steatohepatits to Steatotic Liver Disease: A Long Way
por: Cotrim, Helma Pinchemel
Publicado: (2023)

Future Perspectives in Pediatric Dentistry: Where are We Now and where are We Heading?
por: Rodrigues, Jonas A, et al.
Publicado: (2022)

LoRaWAN Mesh Networks: A Review and Classification of Multihop Communication
por: Cotrim, Jeferson Rodrigues, et al.
Publicado: (2020)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
por: Mesnier, Jules, et al.
Publicado: (2022)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_que9g2rjhe85c8eui037pgs1mr